Serum Neuroinflammatory Disease-Induced Central Nervous System Proteins Predict Clinical Onset of Experimental Autoimmune Encephalomyelitis

There is an urgent need in multiple sclerosis (MS) patients to develop biomarkers and laboratory tests to improve early diagnosis, predict clinical relapses, and optimize treatment responses. In healthy individuals, the transport of proteins across the blood–brain barrier (BBB) is tightly regulated,...

Descripción completa

Detalles Bibliográficos
Autores principales: Raphael, Itay, Webb, Johanna, Gomez-Rivera, Francisco, Chase Huizar, Carol A., Gupta, Rishein, Arulanandam, Bernard P., Wang, Yufeng, Haskins, William E., Forsthuber, Thomas G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512177/
https://www.ncbi.nlm.nih.gov/pubmed/28769926
http://dx.doi.org/10.3389/fimmu.2017.00812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512177/
https://www.ncbi.nlm.nih.gov/pubmed/28769926
http://dx.doi.org/10.3389/fimmu.2017.00812

Ejemplares similares